Rhythm Pharmaceuticals (RYTM) Change in Receivables (2022 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Change in Receivables of $8.1 million for Q1 2026, up 1280.49% year-over-year from $587470.5 in Q1 2025, and up 231.34% quarter-over-quarter from -$6.2 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Change in Receivables (2022 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Change in Receivables for 5 consecutive years, with $8.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables rose 1280.49% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $16.4 million (up 422.91% YoY), while the FY2025 annual figure was $7.6 million, up 107.68% from the prior year.
- Change in Receivables advanced to $8.1 million in Q1 2026 per RYTM's latest filing, from -$6.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $8.1 million in Q1 2026 and bottomed at -$6.2 million in Q4 2025.
- Historically, Change in Receivables has averaged $2.1 million across 5 years, with a median of $1.7 million in 2024.
- Annual changes were most pronounced in 2025 — Change in Receivables slumped 677.71% — and 2026, when it surged 1280.49%.
- Rhythm Pharmaceuticals' Change in Receivables stood at $2.9 million in 2022, then sank by 88.74% to $326000.0 in 2023, then plunged by 343.56% to -$794000.0 in 2024, then plunged by 677.71% to -$6.2 million in 2025, then surged by 231.34% to $8.1 million in 2026.
- Business Quant data shows RYTM's Change in Receivables at $8.1 million in Q1 2026, -$6.2 million in Q4 2025, and $6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 6.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.22 Mn |
| Jun 30, 2026 | 6.22 Mn |
| Mar 31, 2026 | 8.11 Mn |
| Mar 31, 2026 | 8.11 Mn |
| Dec 31, 2025 | -6.18 Mn |
| Dec 31, 2025 | -6.18 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | -687,000.00 |
| Mar 31, 2025 | -687,000.00 |
| Dec 31, 2024 | -794,000.00 |
| Dec 31, 2024 | -794,000.00 |
| Sep 30, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | -172,000.00 |
| Mar 31, 2024 | -172,000.00 |